Radiotherapy treatment planning software developer MVision AI has entered into a distribution agreement with Medron Medical Systems of Ottawa, Ontario, Canada.
Subject to approval from Health Canada, Medron Medical will distribute MVision AI's offerings throughout that country, including its GBAIS artificial intelligence (AI)-based segmentation software, the two firms said.
